INVITAE CORPORATION

(NVTA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Invitae Reports Jump in Revenue, Billable Volume for 2021

01/10/2022 | 01:36pm EDT


© MT Newswires 2022
All news about INVITAE CORPORATION
05/19Invitae Launches Expanded Pharmacogenomics Panel and Specialized Mental Health Panel
PR
05/19Invitae Corporation Launches Expanded Pharmacogenomics Panel and Specialized Mental Hea..
CI
05/11NeoGenomics Appoints Vishal Sikri as President
MT
05/05Raymond James Adjusts Invitae's Price Target to $8.50 From $10.50, Keeps Outperform Rat..
MT
05/03INVITAE CORP Management's Discussion and Analysis of Financial Condition and Results o..
AQ
05/03Invitae Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/03INVITAE : Q1 Earnings Snapshot
AQ
05/03TRANSCRIPT : Invitae Corporation, Q1 2022 Earnings Call, May 03, 2022
CI
05/03Invitae Corporation Provides Revenue Guidance for the Second Quarter of 2022
CI
05/03Earnings Flash (NVTA) INVITAE CORPORATION Posts Q1 Loss $-0.78, vs. Street Est of $-0.7..
MT
More news
Analyst Recommendations on INVITAE CORPORATION
More recommendations
Financials (USD)
Sales 2022 628 M - -
Net income 2022 -765 M - -
Net Debt 2022 1 151 M - -
P/E ratio 2022 -1,12x
Yield 2022 -
Capitalization 832 M 832 M -
EV / Sales 2022 3,16x
EV / Sales 2023 2,38x
Nbr of Employees 2 900
Free-Float 98,1%
Chart INVITAE CORPORATION
Duration : Period :
Invitae Corporation Technical Analysis Chart | NVTA | US46185L1035 | MarketScreener
Technical analysis trends INVITAE CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 9
Last Close Price 3,63 $
Average target price 15,41 $
Spread / Average Target 324%
EPS Revisions
Managers and Directors
Sean Emerson George Director
Roxi Wen Chief Financial Officer
Robert L. Nussbaum Chief Medical Officer
Eric Olivares Chief Science Officer
Karthik Suri Chief Product & Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
INVITAE CORPORATION-76.23%832
EXACT SCIENCES CORPORATION-31.68%9 355
BGI GENOMICS CO., LTD.-24.52%4 059
GUARDANT HEALTH, INC.-63.24%3 748
IOVANCE BIOTHERAPEUTICS, INC.-19.17%2 425
SEEGENE, INC.-30.57%1 715